C
COSM
vs
S&P 500
S&P 500
Over the past 12 months, COSM has underperformed S&P 500, delivering a return of -21% compared to the S&P 500's +14% growth.
Stocks Performance
COSM vs S&P 500
Performance Gap
COSM vs S&P 500
Performance By Year
COSM vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cosmos Holdings Inc
Glance View
Cosmos Holdings, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Chicago, Illinois. The company went IPO on 2010-05-19. The firm imports, exports and distributes pharmaceutical products of brand-name and generic pharmaceuticals, over-the-counter (OTC) medicines, and a variety of dietary and vitamin supplements through its distribution network. The firm operates its business through its subsidiaries: SkyPharm, Decahedron Ltd and Cosmofarm. SkyPharm is principally engaged in creating, developing and trading of its own branded nutraceutical products line, Sky Premium Life. Decahedron is engaged in trading branded and generic pharmaceutical products and medicines across the European Union (EU) member states. Cosmofarm is engaged in distribution of branded pharmaceutical products, OTC products, cosmetics, nursery, and dietary products to pharmacies across Greece. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, United Kingdom.